Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications
Meidan Ding, Fangfang Guo, Ping Lin · 2026
Read Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications by Meidan Ding, Fangfang Guo, Ping Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13275647.txt.
Description
Meidan Ding, Fangfang Guo, and Ping Lin review a licorice compound called isoliquiritigenin in ovarian cancer, in a 2026 article. Ovarian cancer is a leading cause of cancer death in women and often returns after treatment. The review asks how this natural compound acts on the JAK/STAT signalling pathway inside tumour cells.
The authors gather cell, animal, and early laboratory studies of the compound. It appears to restrain tumour growth through several targets on the pathway at once. Low toxicity and possible help against drug resistance add to its appeal. The review presents it as a candidate for combination treatment, while noting that human evidence is still lacking.
Catalog record
| CREATOR | Meidan Ding, Fangfang Guo, Ping Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |